PubRank

A C Fluit

Author PubWeight™ 146.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001 5.28
2 The magnetic immuno polymerase chain reaction assay for direct detection of salmonellae in fecal samples. J Clin Microbiol 1992 3.56
3 Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Düsseldorf area. J Antimicrob Chemother 1999 3.42
4 Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. J Antimicrob Chemother 1998 3.21
5 International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe). Diagn Microbiol Infect Dis 1999 3.11
6 Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 2011 2.83
7 Comparison of genotypic and phenotypic methods for species-level identification of clinical isolates of coagulase-negative staphylococci. J Clin Microbiol 2005 2.56
8 Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001 2.39
9 Transmission of methicillin-resistant Staphylococcus aureus strains between different kinds of pig farms. Vet Microbiol 2007 2.16
10 In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected]. Lancet 2001 2.14
11 Methicillin-resistant staphylococci isolated from animals. Vet Microbiol 2004 2.01
12 Evaluation of the magnetic immuno PCR assay for rapid detection of Salmonella. Eur J Clin Microbiol Infect Dis 1991 1.85
13 Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates. Antimicrob Agents Chemother 2003 1.76
14 Many class I integrons comprise distinct stable structures occurring in different species of Enterobacteriaceae isolated from widespread geographic regions in Europe. Antimicrob Agents Chemother 1999 1.75
15 The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J Antimicrob Chemother 1998 1.71
16 Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group. J Antimicrob Chemother 1999 1.69
17 Rapid detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis. J Antimicrob Chemother 2010 1.68
18 [Fatal pneumonia in an adolescent due to community-acquired methicillin-resistant Staphylococcus aureus positive for Panton-Valentine-leukocidin]. Ned Tijdschr Geneeskd 2003 1.68
19 The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals. J Antimicrob Chemother 1999 1.68
20 Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and -susceptible European isolates of Staphylococcus aureus. J Antimicrob Chemother 2001 1.59
21 False-positive results and contamination in nucleic acid amplification assays: suggestions for a prevent and destroy strategy. Eur J Clin Microbiol Infect Dis 2004 1.57
22 Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates. FEMS Immunol Med Microbiol 1999 1.51
23 Cloning and characterization of an accessory gene regulator (agr)-like locus from Staphylococcus epidermidis. FEMS Microbiol Lett 1998 1.48
24 Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 2001 1.48
25 The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 1998 1.48
26 Presence of integron-associated resistance in the community is widespread and contributes to multidrug resistance in the hospital. J Clin Microbiol 2002 1.46
27 Short term micro-evolution and PCR-detection of methicillin-resistant and -susceptible Staphylococcus aureus sequence type 398. Eur J Clin Microbiol Infect Dis 2009 1.42
28 Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe. Eur J Clin Microbiol Infect Dis 2000 1.42
29 Rapid identification of bacteria by PCR-single-strand conformation polymorphism. J Clin Microbiol 1994 1.41
30 Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J Antimicrob Chemother 2000 1.40
31 Molecular identification of bacteria by fluorescence-based PCR-single-strand conformation polymorphism analysis of the 16S rRNA gene. J Clin Microbiol 1995 1.38
32 Novel mobile variants of staphylococcal cassette chromosome mec in Staphylococcus aureus. Antimicrob Agents Chemother 2006 1.35
33 A set of multiplex PCRs for genotypic detection of extended-spectrum β-lactamases, carbapenemases, plasmid-mediated AmpC β-lactamases and OXA β-lactamases. Int J Antimicrob Agents 2011 1.34
34 Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping. J Clin Microbiol 2000 1.32
35 Novel gene cassettes and integrons. Antimicrob Agents Chemother 2001 1.31
36 mecA gene is widely disseminated in Staphylococcus aureus population. J Clin Microbiol 2002 1.30
37 Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis. J Clin Microbiol 2003 1.29
38 Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit. J Hosp Infect 2002 1.29
39 Methicillin-resistant Staphylococcus aureus in horses and horse personnel: an investigation of several outbreaks. Vet Microbiol 2009 1.25
40 Cloning and occurrence of czrC, a gene conferring cadmium and zinc resistance in methicillin-resistant Staphylococcus aureus CC398 isolates. Antimicrob Agents Chemother 2010 1.24
41 Increased prevalence of class I integrons in Escherichia coli, Klebsiella species, and Enterobacter species isolates over a 7-year period in a German university hospital. J Clin Microbiol 2001 1.23
42 In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates. Antimicrob Agents Chemother 2000 1.23
43 Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 2003 1.22
44 Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates. J Antimicrob Chemother 2001 1.22
45 Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents 2004 1.20
46 Rapid detection of toxigenic Clostridium difficile in fecal samples by magnetic immuno PCR assay. J Clin Microbiol 1994 1.19
47 Comparison of the identification of coagulase-negative staphylococci by matrix-assisted laser desorption ionization time-of-flight mass spectrometry and tuf sequencing. Eur J Clin Microbiol Infect Dis 2011 1.18
48 Fluoroquinolones: structure and target sites. Curr Drug Targets 2003 1.17
49 Distribution of macrolide-resistance genes in Staphylococcus aureus blood-culture isolates from fifteen German university hospitals. M.A.R.S. Study Group. Multicentre Study on Antibiotic Resistance in Staphylococci. Eur J Clin Microbiol Infect Dis 2000 1.15
50 A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin. Clin Microbiol Infect 2013 1.13
51 Susceptibility of 302 methicillin-resistant Staphylococcus aureus isolates from 20 European university hospitals to vancomycin and alternative antistaphylococcal compounds. SENTRY Participants Group. Eur J Clin Microbiol Infect Dis 1999 1.12
52 Monoclonal antibodies that react with live Listeria spp. Appl Environ Microbiol 1993 1.12
53 Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother 2000 1.09
54 In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus. Antimicrob Agents Chemother 2001 1.08
55 Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme. Eur J Clin Microbiol Infect Dis 1999 1.07
56 Transmission of methicillin-resistant Staphylococcus intermedius between humans and animals. Vet Microbiol 2007 1.06
57 Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance. Eur J Clin Microbiol Infect Dis 2002 1.03
58 Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins. Antimicrob Agents Chemother 1999 1.02
59 An algorithm to estimate the importance of bacterial acquisition routes in hospital settings. Am J Epidemiol 2007 1.01
60 Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011. Euro Surveill 2014 1.00
61 Monoclonal antibodies that detect live salmonellae. Appl Environ Microbiol 1992 1.00
62 Comparison of typing methods for Clostridium difficile isolates. J Clin Microbiol 1993 1.00
63 Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an International Surveillance Programme. SENTRY Participants Group. Eur J Clin Microbiol Infect Dis 1999 0.99
64 Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998. Microb Drug Resist 2000 0.99
65 Detection of Candida spp. in blood cultures using nucleic acid sequence-based amplification (NASBA). Diagn Microbiol Infect Dis 2001 0.94
66 Control of nosocomial multiresistant Enterobacteriaceae using a temporary restrictive antibiotic agent policy. Eur J Clin Microbiol Infect Dis 2001 0.93
67 Nucleic acid sequence-based amplification (NASBA) detection of medically important Candida species. J Microbiol Methods 1999 0.93
68 Phenotypic characterization of epidemic versus sporadic strains of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1995 0.92
69 Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation. J Virol 1988 0.92
70 Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates. Int J Antimicrob Agents 2001 0.92
71 Phagocytosis of herpes simplex virus by human granulocytes and monocytes. Arch Virol 1989 0.90
72 Characterization of Dutch Staphylococcus aureus from bovine mastitis using a Multiple Locus Variable Number Tandem Repeat Analysis. Vet Microbiol 2008 0.90
73 [Methicillin resistant Staphylococcus aureus (MRSA) infection in a dog in the Netherlands]. Tijdschr Diergeneeskd 2003 0.88
74 Resistance to trimethoprim-sulfamethoxazole and modifications in genes coding for dihydrofolate reductase and dihydropteroate synthase in European Streptococcus pneumoniae isolates. J Antimicrob Chemother 2001 0.88
75 Detection of Salmonella species in fecal samples by immunomagnetic separation and PCR. J Clin Microbiol 1995 0.88
76 The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial. Int J Antimicrob Agents 2004 0.88
77 Degradation of herpes simplex virions by human polymorphonuclear leukocytes and monocytes. J Gen Virol 1990 0.88
78 Effect of SSB protein on cleavage of single-stranded DNA by phi X gene A protein and A* protein. Nucleic Acids Res 1986 0.87
79 Colonization with multiple Staphylococcus aureus strains among patients in European intensive care units. Infect Control Hosp Epidemiol 2009 0.87
80 Bacterial resistance: a sensitive issue complexity of the challenge and containment strategy in Europe. Drug Resist Updat 2006 0.87
81 Relationship between mutations in the coding and promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains. J Antimicrob Chemother 1998 0.86
82 Molecular analyses of possible mechanisms coding for low-level mupirocin resistance in clinical Staphylococcus aureus isolates. Eur J Clin Microbiol Infect Dis 2000 0.86
83 Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children. Gut 1994 0.86
84 Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 2006 0.86
85 Comparison of immunomagnetic beads coated with protein A, protein G, or goat anti-mouse immunoglobulins. Applications in enzyme immunoassays and immunomagnetic separations. J Immunol Methods 1993 0.85
86 Comparative activity of 27 antimicrobial compounds against 698 Streptococcus pneumoniae isolates originating from 20 European university hospitals. SENTRY Participants Group. Eur J Clin Microbiol Infect Dis 1999 0.84
87 Evaluation of a commercial microarray as a confirmation test for the presence of extended-spectrum β-lactamases in isolates from the routine clinical setting. Clin Microbiol Infect 2011 0.83
88 Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibiotics. J Antimicrob Chemother 2000 0.83
89 Antimicrobial susceptibility of imipenem-resistant Pseudomonas aeruginosa. J Antimicrob Chemother 2002 0.83
90 Hair follicles as a niche of Staphylococcus aureus in the nose; is a more effective decolonisation strategy needed? J Hosp Infect 2010 0.83
91 Comparison of E test and double disk diffusion test for detection of extended spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis 2002 0.83
92 Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolones. Antimicrob Agents Chemother 1999 0.82
93 Comparative activities of six different fluoroquinolones against 9,682 clinical bacterial isolates from 20 European university hospitals participating in the European SENTRY surveillance programme. The SENTRY participants group. Int J Antimicrob Agents 1999 0.82
94 Structural alterations in the translational attenuator of constitutively expressed erm(A) genes in Staphylococcus aureus. Antimicrob Agents Chemother 2001 0.82
95 Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population. Antimicrob Agents Chemother 2010 0.81
96 Quinolone-resistance mechanisms and in vitro susceptibility patterns among European isolates of Streptococcus mitis, Streptococcus sanguis, and Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 2001 0.81
97 Propensity of fluoroquinolones with different moieties at position 8 to cause resistance development in clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 2001 0.81
98 In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis. J Antimicrob Chemother 2002 0.81
99 Differences in the antibiotic susceptibility of human Escherichia coli with poultry-associated and non-poultry-associated extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis 2013 0.80
100 Uncoupling of oxidative and non-oxidative mechanisms in human granulocyte-mediated cytotoxicity: use of cytoplasts and cells from chronic granulomatous disease patient. J Leukoc Biol 1990 0.80
101 Multi-centre evaluation of a phenotypic extended spectrum β-lactamase detection guideline in the routine setting. Clin Microbiol Infect 2012 0.80
102 Detection of toxigenic Clostridium difficile in fecal samples by colony blot hybridization. Eur J Clin Microbiol Infect Dis 1993 0.80
103 Sex-limited protein: in vitro and in vivo functions. Clin Exp Immunol 1999 0.80
104 Invasive and noninvasive group A streptococcal isolates with different speA alleles in The Netherlands: genetic relatedness and production of pyrogenic exotoxins A and B. J Clin Microbiol 1999 0.79
105 Detection of enterovirulent Escherichia coli associated with diarrhoea in Seville, southern Spain, with non-radioactive DNA probes. J Med Microbiol 1993 0.79
106 Frequency of enterovirulent Escherichia coli in diarrhoeal disease in The Netherlands. Eur J Clin Microbiol Infect Dis 1993 0.79
107 Development of chromosomally encoded resistance mutations in small-colony variants of Staphylococcus aureus. J Antimicrob Chemother 2001 0.79
108 Resistance to beta-lactams among blood isolates of Salmonella spp. in European hospitals: results from the SENTRY Antimicrobial Surveillance Program 1997-98. Clin Microbiol Infect 2003 0.78
109 Cross-resistance analyses and molecular typing of Staphylococcus aureus and Streptococcus spp. isolates resistant to quinupristin/dalfopristin. J Antimicrob Chemother 1999 0.78
110 Induction of in vitro resistance to BMS-284756 by Streptococcus pneumoniae. J Antimicrob Chemother 2001 0.78
111 The complete 30-base-pair origin region of bacteriophage phi X174 in a plasmid is both required and sufficient for in vivo rolling-circle DNA replication and packaging. Eur J Biochem 1985 0.78
112 The effect of culture conditions on the in-vitro adherence of methicillin-resistant Staphylococcus aureus. J Med Microbiol 1998 0.78
113 Toxins A and B of Clostridium difficile. FEMS Microbiol Rev 1994 0.78
114 Gene A protein cleavage of recombinant plasmids containing the phi X174 replication origin. Nucleic Acids Res 1984 0.77
115 In vitro activity of faropenem and 20 other compounds against beta-lactamase-positive and -negative Moraxella catarrhalis and Haemophilus influenzae isolates and the effect of serum on faropenem MICs. J Antimicrob Chemother 2002 0.77
116 In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 2000 0.76
117 Evaluation of the Oxoid Brilliance™ CRE Agar for the detection of carbapenemase-producing Enterobacteriaceae. Eur J Clin Microbiol Infect Dis 2013 0.76
118 In vitro activity of the novel des-F(6) quinolone BMS-284756 against genetically characterized clinical streptococcal isolates, including isolates with reduced quinolone susceptibility. J Antimicrob Chemother 2002 0.75
119 Further evidence against a role for toxic oxygen products as lytic agents in NK cell-mediated cytotoxicity. Immunology 1987 0.75
120 Evidence of cross-resistance between ciprofloxacin and non-fluoroquinolones in European Gram-negative clinical isolates. J Antimicrob Chemother 2002 0.75
121 Treatment options for Streptococcus pneumoniae strains resistant to macrolides, tetracycline, quinolones, or trimethoprim/sulfamethoxazole. Eur J Clin Microbiol Infect Dis 2001 0.75
122 Reactivity of monoclonal antibodies to Pseudomonas aeruginosa isolates from hospitalized adults and patients with cystic fibrosis. Clin Infect Dis 1994 0.75
123 Evaluation of genetic determinants involved in beta-lactam- and multiresistance in a surgical ICU. Int J Antimicrob Agents 2004 0.75
124 Antibody-coated target cell membrane-induced chemiluminescence by human polymorphonuclear leukocytes. J Immunol Methods 1989 0.75
125 Multivalent binding of toxin A from Clostridium difficile to carbohydrate receptors. Toxicon 1994 0.75
126 Termination and reinitiation signals of bacteriophage phi X174 rolling circle DNA replication. Virology 1986 0.75
127 Quantitation of conjugate formation between human polymorphonuclear leukocytes and antibody-coated target cells by flow cytometry: the role of Fc receptor and LFA-1 antigen. J Leukoc Biol 1989 0.75
128 Characterization of the translational attenuator of 20 methicillin-resistant, quinupristin/dalfopristin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides. J Antimicrob Chemother 2001 0.75
129 The presence of ermB in Streptococcus pneumoniae has no influence on AZD2563 MIC values. J Antimicrob Chemother 2003 0.75
130 Simultaneous Delivery of Multiple Antibacterial Agents from Additively Manufactured Porous Biomaterials to fully Eradicate Planktonic and Adherent Staphylococcus aureus. ACS Appl Mater Interfaces 2017 0.75
131 Enterovirulent Escherichia coli can cause bacteraemia in immunocompromised patients. J Infect 1993 0.75
132 Gene A protein interacting with recombinant plasmid DNAs containing 25-30 b.p. of the phi X174 replication origin. Adv Exp Med Biol 1984 0.75
133 In vitro development of resistance to newer fluoroquinolones in Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin. Eur J Clin Microbiol Infect Dis 2001 0.75
134 [Detection of diarrhea-causing Escherichia coli using DNA-probes]. Ned Tijdschr Geneeskd 1992 0.75
135 In vitro activity of faropenem and 21 other compounds against 385 different genetically characterized isolates of antibiotic-resistant Streptococcus pneumoniae. J Antimicrob Chemother 2001 0.75
136 Detection of staphylococcal genes directly from cerebrospinal and peritoneal fluid samples using a multiplex polymerase chain reaction. Eur J Clin Microbiol Infect Dis 1998 0.75
137 High-level gentamicin resistance in Enterococcus faecium and Enterococcus faecalis blood culture isolates from 23 European university hospitals. Int J Antimicrob Agents 2003 0.75